Catello Somma joined TVM in 2020.
Prior to joining TVM, Catello was global clinical trial manager at Incyte, responsible for the implementation, execution and management of oncology clinical programs for both large and small molecules.
Catello was also a co-founder of a single asset biotech company focused in immuno-oncology.
Catello has 10 years experience in the industry, working for contract research organizations (Parexel, UBC and boutique CROs) and small/mid-sized biotechs (THERAMetrics and Incyte), with responsibilities ranging from clinical to corporate development.
Catello holds an MSc in molecular biology from Federico II University of Naples, Italy and an MBA from MIP – Politecnico di Milano School of Management, Italy